Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
FLUOROURACIL , OXALIPLATIN , GEMCITABINE , FOLIC ACID
Pari Pharma GmbH
Pancreatic adenocarcinoma (PAC)
1 trial -
HYDROXYCHLOROQUINE, METHOTREXATE, Remsima 120 mg solution for injection in pre-filled pen, METHOTREXATE, IBUPROFEN, Placebo (To evaluate the efficacy and safety of CT-P13, and mainatain blindness during the study, Placebo will be administered.), PARACETAMOL, FOLIC ACID, HYDROCORTISONE
Celltrion Healthcare Australia Pty Ltd
Rheumatoid arthritis
1 trial -
Iron (27 mg) - folic acid (600 ug)
United Therapeutics Europe Ltd
Infant Mortality
1 trial -
METHOTREXATE, METHOTREXATE, DESOXIMETASONE, TACROLIMUS, placebo, Acidum folicum Léčiva 10 mg obalené tablety, FOLIC ACID
Medac Gesellschaft fuer klinische Spezialpraeparate mbH
moderate to severe atopic dermatitis
1 trial -
folic acid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Neoplasms
1 trial -
FLUOROURACIL, JZP598, PEMBROLIZUMAB, FOLIC ACID, OXALIPLATIN
The George Institute
Gastroesophageal Adenocarcinoma
1 trial -
Fluorouracil Injection 25 mg/ml, solution for injection, Oncofolic 50 mg/ml, Injektions-/Infusionslösung, Irinotecan Hydrochloride 20 mg/mL concentrate for solution for infusion
Wuhan Createrna Science and Technology Co., Ltd
Metastatic Colorectal Cancer
1 trial -
Ontruzant 420 mg powder for concentrate for solution for infusion, Oxaliplatin onkovis 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung, KEYTRUDA 25 mg/mL concentrate for solution for infusion, TAXOTERE 20 mg/1 ml concentrate for solution for infusion, Oncofolic 50 mg/ml, Injektions-/Infusionslösung, 5-FU medac 50 mg/ml, Injektionslösung
The George Institute
HER2-positive, localized esophagogastric adenocarcinoma
1 trial -
Folic Acid 5 MG
The University of Hong Kong
Acute Kidney Injury
1 trial -
Folic Acid
The First People's Hospital of Lianyungang
Hypertension
1 trial -
Folic Acid
Cardiff Oncology
Depression
1 trial -
Folic Acid
Hospital Authority, Hong Kong
Pregnant Women
1 trial -
Folic Acid
Xijing Hospital
Stroke
1 trial -
Folic acid
CRESCENT BIOPHARMA, INC.
Acute Myocardial Infarction
1 trial -
folic acid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Neural Tube Defects - Spina Bifida and Anencephaly
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources